Trials / Terminated
TerminatedNCT01114464
Impact of Chemotherapy on Ovarian Reserve in Young Women With Breast Cancer
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (actual)
- Sponsor
- Nantes University Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 39 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this protocol is to study the deleterious impact of adjuvant chemotherapy or neoadjuvant chemotherapy on ovarian reserve in young women suffering from breast cancer. A new relevant ovarian reserve marker, serum Anti-Mullerian Hormone, will be used in order to evaluate precisely the impact of chemotherapy on ovaries during chemotherapy administrations and after during follow-up (24 months). This strategy offers 2 main advantages : no modification of the traditional care of patients (treatment, organisation, follow up …) and use of a non invasive marker (serum). The final objective is to give precise information to patients on their future fertility after remission.
Conditions
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2010-05-03
- Last updated
- 2016-08-08
Locations
11 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01114464. Inclusion in this directory is not an endorsement.